Back to top

CHINA PHARMA HOLDINGS, INC. WARRANT

Warrant Agreement

CHINA PHARMA HOLDINGS, INC.


                                     WARRANT | Document Parties: CHINA PHARMA HOLDINGS, INC. You are currently viewing:
This Warrant Agreement involves

CHINA PHARMA HOLDINGS, INC.

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: CHINA PHARMA HOLDINGS, INC. WARRANT
Governing Law: New York     Date: 6/27/2008
Industry: Biotechnology and Drugs     Sector: Healthcare

CHINA PHARMA HOLDINGS, INC.


                                     WARRANT, Parties: china pharma holdings  inc.
50 of the Top 250 law firms use our Products every day

                                      

                                                                    Exhibit 10.1

NEITHER   THESE   SECURITIES   NOR THE   SECURITIES   ISSUABLE UPON EXERCISE OF THESE
SECURITIES HAVE BEEN   REGISTERED WITH THE SECURITIES AND EXCHANGE   COMMISSION OR
THE   SECURITIES   COMMISSION   OF ANY STATE IN   RELIANCE   UPON AN   EXEMPTION   FROM
REGISTRATION   UNDER THE   SECURITIES   ACT OF 1933,   AS AMENDED   (THE   "SECURITIES
ACT"),   AND,   ACCORDINGLY,   MAY NOT BE OFFERED   OR SOLD   EXCEPT   PURSUANT   TO AN
EFFECTIVE   REGISTRATION   STATEMENT   UNDER THE   SECURITIES   ACT OR PURSUANT TO AN
AVAILABLE   EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE   REGISTRATION
REQUIREMENTS   OF THE   SECURITIES   ACT AND IN ACCORDANCE   WITH   APPLICABLE   STATE
SECURITIES   LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH   EFFECT,   THE   SUBSTANCE   OF WHICH SHALL BE   REASONABLY   ACCEPTABLE   TO THE
COMPANY.   THESE   SECURITIES AND THE   SECURITIES   ISSUABLE UPON EXERCISE OF THESE
SECURITIES MAY BE PLEDGED IN CONNECTION   WITH A BONA FIDE MARGIN ACCOUNT SECURED
BY SUCH SECURITIES.



                           CHINA PHARMA HOLDINGS, INC.


                                     WARRANT


                                              Original Issue Date: June 24, 2008

         China Pharma   Holdings,   Inc., a Delaware   corporation (the "Company"),
hereby certifies that, as partial   compensation for its independent   consultant,
FirsTrust Group, Inc. or its registered   assigns (the "Holder"),   is entitled to
purchase   from the Company up to a total of 75,000   shares of Common Stock (each
such share, a "Warrant Share" and all such shares, the "Warrant Shares"), at any
time and from time to time from and after the   Original   Issue Date and   through
and   including   June 24,   2011   (the   "Expiration   Date"),   and   subject   to the
following terms and conditions:

     1. Definitions. As used in this Warrant, the following terms shall have the
respective definitions set forth in this Section 1.

         "Business Day" means any day except Saturday,   Sunday and any day which
is a federal legal holiday or a day on which banking   institutions   in the State
of New York are   authorized or required by law or other   governmental   action to
close.

         "Common Stock" means the common stock of the Company,   par value $0.001
per share,   and any   securities   into which such common   stock may   hereafter be
reclassified.

         "Exercise Price" means $2.8 per share.



                                      
<PAGE>


         "Original   Issue Date" means the Original Issue Date first set forth on
the first page of this Warrant.

         "New York   Courts"   means the state and federal   courts   sitting in the
City of New York, Borough of Manhattan.

          "Trading Day" means (i) a day on which the Common Stock is traded on a
Trading Market or (ii) if the Common Stock is not quoted on any Trading   Market,
a day on which the   Common   Stock is quoted   in the   over-the-counter   market as
reported   by the   Pink   Sheets   LLC   (or   any   similar   organization   or   agency
succeeding to its functions of reporting   prices);   provided,   that in the event
that the   Common   Stock is not   listed   or   quoted   as set   forth in (i) or (ii)
hereof, then Trading Day shall mean a Business Day.

         "Trading   Market" means whichever of the New York Stock   Exchange,   the
American   Stock   Exchange,   the NASDAQ Global Select   Market,   the NASDAQ Global
Market,   the NASDAQ   Capital   Market or OTC   Bulletin   Board on which the Common
Stock is listed or quoted for trading on the date in question.

     2.   Registration   of Warrant.   The Company shall register this Warrant upon
records   to be   maintained   by   the   Company   for   that   purpose   (the   "Warrant
Register"),   in the name of the   record   Holder   hereof   from time to time.   The
Company may deem and treat the registered Holder of this Warrant as the absolute
owner hereof for the purpose of any exercise   hereof or any   distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.

     3.   Registration   of Transfers.   The Company shall register the transfer of
any portion of this   Warrant in the Warrant   Register,   upon   surrender   of this
Warrant,   with the Form of Assignment attached hereto duly completed and signed,
to the Company at its address   specified   herein.   Upon any such registration or
transfer,   a new Warrant to purchase Common Stock, in substantially   the form of
this Warrant (any such new Warrant, a "New Warrant"),   evidencing the portion of
this Warrant so transferred   shall be issued to the transferee and a New Warrant
evidencing   the remaining   portion of this Warrant not so   transferred,   if any,
shall be issued to the transferring Holder. The acceptance of the New Warrant by
the transferee   thereof shall be deemed the acceptance by such transferee of all
of the rights and obligations of a holder of a Warrant.

     4. Exercise and Duration of Warrants.

         This Warrant shall be exercisable by the registered   Holder at any time
and from time to time on or after the Original   Issue Date through and including
the Expiration   Date. At 6:30 p.m.,   New York City time on the Expiration   Date,
the portion of this Warrant not exercised prior thereto shall be and become void
and of no value.   The Company may not call or redeem any portion of this Warrant
without the prior written consent of the affected Holder.

     5. Delivery of Warrant Shares.

         (a) To   effect   exercises   hereunder,   subject   to the   request   of the
transfer   agent of the Company,   the Holder shall not be required to   physically
surrender this Warrant unless the aggregate   Warrant Shares   represented by this
Warrant is being   exercised.   Upon delivery of the Warrant (if   necessary),   the



                                        2
<PAGE>

Exercise Notice (in the form attached   hereto) to the Company (with the attached
Warrant Shares Exercise Log) at its address for notice set forth herein and upon
payment of the Exercise   Price   multiplied by the number of Warrant   Shares that
the Holder intends to purchase hereunder,   the Company shall promptly (but in no
event   later than five   Trading   Days   after the Date of   Exercise   (as   defined
herein)) issue and deliver to the Holder,   a certificate   for the Warrant Shares
issuable upon such   exercise.   A "Date of Exercise"   means the date on which the
Holder shall have   delivered to the   Company:   (i) this Warrant (if   necessary),
(ii) the   Exercise   Notice   (with the   Warrant   Exercise   Log   attached   to it),
appropriately   completed and duly signed and (iii) payment of the Exercise Price
for the number of Warrant Shares so indicated by the Holder to be purchased.

         (b) If by the fifth   Trading Day after a Date of   Exercise   the Company
fails to deliver the required   number of Warrant   Shares in the manner   required
pursuant to Section   5(a),   then the Holder will have the right to rescind   such
exercise.

         (c) If by the fifth   Trading Day after a Date of   Exercise   the Company
fails to deliver the required   number of Warrant   Shares in the manner   required
pursuant to Section   5(a),   and if after such fifth Trading Day and prior to the
receipt   of such   Warrant   Shares,   the   Holder   purchases   (in an   open   market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a
sale by the Holder of the Warrant Shares which the Holder anticipated   receiving
upon such exercise (a   "Buy-In"),   then the Company shall (1) pay in cash to the
Holder the amount by which (x) the   Holder's   total   purchase   price   (including
brokerage   commissions,   if any) for the   shares   of Common   Stock so   purchased
exceeds (y) the amount   obtained by multiplying (A) the number of Warrant Shares
that the Company was   required to deliver to the Holder in   connection   with the
exercise at issue by (B) the   closing bid price of the Common   Stock on the Date
of Exercise and (2) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent   number of Warrant Shares for which such exercise was
not   honored or deliver to the Holder the number of shares of Common   Stock that
would have been issued had the Company   timely   complied   with its   exercise and
delivery   obligations   hereunder.   The Holder shall provide the Company   written
notice indicating the amounts payable to the Holder in respect of the Buy-In.

         (d) The Company's   obligations   to issue and deliver   Warrant Shares in
accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same,   any waiver or consent
with respect to any provision   hereof,   the recovery of any judgment against any
Person   or   any   action   to   enforce   the   same,   or any   setoff,   counterclaim,
recoupment,   limitation or   termination,   or any breach or alleged breach by the
Holder or any other Person of any   obligation to the Company or any violation or
alleged violation of law by the Holder or any other Person,   and irrespective of
any other   circumstance   which   might   otherwise   limit such   obligation   of the
Company to the Holder in connection with the issuance of Warrant Shares. Nothing
herein shall limit a Holder's right to pursue any other remedies available to it
hereunder,   at law or in   equity   including,   without   limitation,   a decree   of
specific   performance   and/or   injunctive   relief with respect to the   Company's
failure to timely deliver certificates representing Warrant Shares upon exercise
of the Warrant as required pursuant to the terms hereof.



                                        3
<PAGE>


     6.   Charges,   Taxes and E  


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more